Prognostic Factors for Clinical Outcome and Cartilage Regeneration after Implantation of Allogeneic Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Large-Sized Cartilage Defects with Osteoarthritis

被引:2
|
作者
Jung, Se-Han [1 ,2 ]
Jung, Min [1 ,3 ]
Chung, Kwangho [1 ,4 ]
Kim, Sungjun [5 ]
Park, Jisoo [1 ,2 ]
Hong, Junseok [3 ]
Choi, Chong-Hyuk [1 ,3 ]
Kim, Sung-Hwan [1 ,2 ]
机构
[1] Yonsei Univ, Arthroscopy & Joint Res Inst, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Orthoped Surg, 211 Eonju Ro, Seoul 06273, South Korea
[3] Yonsei Univ, Coll Med, Severance Hosp, Dept Orthoped Surg, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Orthoped Surg, Yongin, South Korea
[5] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea
关键词
osteoarthritis; cartilage defect; cartilage repair; mesenchymal stem cell; stem cell therapy; AUTOLOGOUS CHONDROCYTE IMPLANTATION; WESTERN-ONTARIO; KNEE; REPAIR; RESPONSIVENESS; TRIAL; INDEX; FORM;
D O I
10.1177/19476035241231372
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objective: To analyze the prognostic factors for clinical outcomes and cartilage regeneration after the implantation of allogeneic human umbilical cord blood mesenchymal stem cell (hUCB-MSC) for treating large-sized cartilage defects with osteoarthritis. Design: This study is a case-series with multiple subgroup analyses that divides the included patients into multiple subgroups based on various factors. Overall, 47 patients who underwent hUCB-MSC implantation were included. The patient-reported outcomes, magnetic resonance imaging (MRI), and second-look arthroscopy were used to assess the outcomes. Results: Combined realignment surgery significantly correlated with clinical outcomes, particularly pain. No other factors significantly influenced the clinical outcomes in short-term period. Subgroups with large defect sizes or meniscal insufficiency showed significantly poor MRI and arthroscopy outcomes (MRI, P = 0.001, P = 0.001; arthroscopy, P = 0.032, P = 0.042). The logistic regression showed that patients with a 1 cm(2) larger defect size were 1.91 times less likely to achieve favorable MRI outcomes (P = 0.017; odds ratio [OR], 1.91). Cut-off value to predict the poor outcome was >5.7 cm(2) (area under the curve, 0.756). A cartilage defect size >5.7 cm(2) was the major poor prognostic factor for cartilage regeneration on MRI (P = 0.010; OR, 17.46). If the postoperative alignment shifted by 1 degrees opposite to the cartilage defect, it was 1.4 times more likely to achieve favorable MRI outcomes (P = 0.028; OR, 1.4). Conclusion: Combining realignment surgery showed a better prognosis for pain improvement. Cartilage defect size, meniscal function, and postoperative alignment are significant prognostic factors for cartilage regeneration. A cartilage defect size >5.7 cm(2) was significantly related to poor cartilage regeneration.
引用
收藏
页码:375 / 388
页数:14
相关论文
共 50 条
  • [31] HUMAN UMBILICAL CORD BLOOD-DERIVED MESENCHYMAL STEM CELLS AND HYALURONIC ACID HYDROGEL COMPOSITE PROMOTES THE ARTICULAR CARTILAGE REPAIR IN A RABBIT MODEL
    Ha, C. -W.
    Kim, J. -A.
    Han, W. -J.
    Rhim, J.
    Shim, J. -H.
    Kim, M. -J.
    Heo, S. -A.
    Park, Y. -B.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S463 - S463
  • [33] Human Umbilical Cord Blood-Derived Stromal Cells Are Superior to Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Inducing Myeloid Lineage Differentiation In Vitro
    Sun, Hao-Ping
    Zhang, Xi
    Chen, Xing-Hua
    Zhang, Cheng
    Gao, Lei
    Feng, Yi-Mei
    Peng, Xian-Gui
    Gao, Li
    STEM CELLS AND DEVELOPMENT, 2012, 21 (09) : 1429 - 1440
  • [34] Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro
    Kang, Xin-Qin
    Zang, Wei-Jin
    Bao, Li-Jun
    Li, Dong-Ling
    Xu, Xiao-Li
    Yu, Xiao-Hang
    CELL BIOLOGY INTERNATIONAL, 2006, 30 (07) : 569 - 575
  • [35] In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells
    Gang, EJ
    Hong, SH
    Jeong, JA
    Hwang, SH
    Kim, SW
    Yang, IH
    Ahn, CY
    Han, H
    Kim, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (01) : 102 - 108
  • [36] The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro
    Wang, Meng
    Yang, Yuan
    Yang, Dongming
    Luo, Fei
    Liang, Wenjie
    Guo, Shuquan
    Xu, Jianzhong
    IMMUNOLOGY, 2009, 126 (02) : 220 - 232
  • [37] Chondrogenic differentiation of human umbilical cord blood-derived mesenchymal stem cells in vitro
    Ibrahim, Azza Mostafa
    Elgharabawi, Nesrine Mohamed
    Makhlouf, Manal Mohamed
    Ibrahim, Omnia Yahia
    MICROSCOPY RESEARCH AND TECHNIQUE, 2015, 78 (08) : 667 - 675
  • [38] The clinical outcomes of intra-articular injection of human umbilical cord blood-derived mesenchymal stem cells vs. bone marrow aspirate concentrate in cartilage regeneration: a systematic review
    Wang, P. -F.
    Xing, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (16) : 7533 - 7543
  • [39] Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell Implantation Versus Microfracture for Large, Full-Thickness Cartilage Defects in Older Patients: A Multicenter Randomized Clinical Trial and Extended 5-Year Clinical Follow-up
    Lim, Hong-Chul
    Park, Yong-Beom
    Ha, Chul-Won
    Cole, Brian J.
    Lee, Beom-Koo
    Jeong, Hwa-Jae
    Kim, Myung-Ku
    Bin, Seong-Il
    Choi, Chong-Hyuk
    Choi, Choong Hyeok
    Yoo, Jae-Doo
    ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE, 2021, 9 (01)
  • [40] Allogeneic Umbilical Cord-Blood-Derived Mesenchymal Stem Cells and Hyaluronate Composite Combined with High Tibial Osteotomy for Medial Knee Osteoarthritis with Full-Thickness Cartilage Defects
    Park, Yong-Beom
    Lee, Han-Jun
    Nam, Hyun-Cheul
    Park, Jung-Gwan
    MEDICINA-LITHUANIA, 2023, 59 (01):